Rigel Pharmaceuticals Advances Drug Pipeline for Rare Diseases

San Francisco, Sunday, 7 December 2025.
Rigel Pharmaceuticals has announced significant progress in its drug pipeline, focusing on rare disease therapies. The company will present its findings at next month’s BioPharma conference.